EAE/ASE 3D Echocardiography Image Acquisition Recommendations
Leading societies provide practical guide for 3DE
Leading societies provide practical guide for 3DE
Philadelphia, PA, January 3 2012 – For the first time, a joint committee of the European Association for Echocardiography and the American Society of Echocardiography have issued recommendations on image acquisition using three-dimensional echocardiography (3DE). ’The EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography’, are available in the January 2012 issue of the Journal of the American Society of Echocardiography (JASE), published by Elsevier.
The recommendations are a practical guide on how to acquire, analyze, and display the various cardiac structures using 3DE, and discuss the advantages and limitations of this technique. The document also describes current and potential clinical applications of 3DE and its specific strengths and weaknesses in each scenario. The same issue of JASE includes articles that explore novel applications of 3DE and illustrate the clinical relevance of this technique. These studies include, ‘Geometric Assessment of Regional Left Ventricular Remodeling by 3D Echocardiographic Shape Analysis Correlates with Left Ventricular Function’, by Ivan S. Salgo et al., ‘Three dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation’, by Alexandra Goncalves et al., and ‘Automated Quantification of Mitral Inflow and Aortic Outflow Stroke Volumes By 3-D Real-Time Volume Color Flow Doppler Transthoracic Echocardiography: Comparison with Pulsed Wave Doppler and Cardiac Magnetic Resonance Imaging’, by Paaladinesh Thavendiranathan et al.
3D echocardiography has been of considerable interest to researchers for more than 30 years, but improvements in imaging technology have made this technique more suitable for clinical use. Editor-in-Chief Dr. Alan S. Pearlman states, “I believe that real-time volumetric imaging using 3D echocardiography now provides a practical way to measure ventricular volumes and ejection fraction without making any assumptions about chamber geometry, and suspect that one day this imaging method will surpass current 2D echo imaging, just as 25 years ago 2D imaging supplanted M-mode echocardiography.”
It is increasingly clear that 3D echo provides unique views in patients with valvular and congenital heart disorders, and the clinical use of this technique is likely to grow rapidly.
# # #
About the Journal of the American Society of Echocardiography
Journal of the American Society of Echocardiography (JASE) – official publication of the American Society of Echocardiography – brings physicians and sonographers the very latest clinical, scientific, legal, and economic information regarding the use of cardiac ultrasound. The journal's original, peer-reviewed articles cover conventional procedures as well as newer clinical techniques, such as transesophageal echocardiography, intraoperative echocardiography, and intravascular ultrasound.
JASE has a 2010 Impact Factor of 3.518 and ranks 30 of 114 journals in the Cardiac & Cardiovascular Systems, according to Thomson Reuters Journal Citation Reports®.
About the Editor-in-Chief
Alan S. Pearlman, MD, FASE, has been Editor-in-Chief of JASE since January 2008. He is a practicing non-invasive cardiologist at the University of Washington in Seattle, where he holds the rank of Professor of Medicine, and is a Past-President of ASE.
About the American Society of Echocardiography
As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines. Comprising more than 15,000 physicians, sonographers, nurses, and scientists, ASE is a strong voice providing guidance, expertise, and education to its members with a commitment to improving the practice of ultrasound and imaging of the heart and cardiovascular system for better patient outcomes. Full text of ASE’s guidelines is available at onlinejase.com. For more information about ASE, visit www.asecho.org or ASE’s public information site, www.SeeMyHeart.org.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+ 1 215 239 3249